Nearly 400 Novel Medicines in Development for Infectious Diseases

America’s biopharmaceutical research companies are developing 394 new medicines for infectious diseases, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA). 

Alzheimer’s - The Puzzle, The Partners, The Path Forward

Alzheimer’s Disease (AD) is a debilitating neurodegenerative disease that currently afflicts more than 5 million people in the U.S. In an effort to catalyze progress in AD innovation and R&D, PhRMA, in partnership with the Alzheimer’s Association and the Alzheimer’s Drug Discovery Foundation, is hosting an all-day forum to convene top industry and academic scientists, patients, policymakers, and other stakeholders.

PhRMA 2013 Industry Profile

Medicines in Development for Vaccines 2013

America’s biopharmaceutical companies are currently developing 271 vaccines to prevent – and in some cases treat – a variety of conditions, including infectious diseases, various forms of cancer and neurological disorders, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA) 

Clinical Trials: Neurological Disorders

There are more than 2,000 clinical trials listed in the National Institutes of Health database – www.clinicaltrials.gov – for neurological disorders, such as Alzheimer’s disease, brain tumors, chronic pain, epilepsy, headache, multiple sclerosis and Parkinson’s disease.  Of those trials, more than 350 are either recruiting patients or have not yet started recruiting patients.  This information is potentially valuable to patients still seeking effective treatments for one of the many neurological disorders.  It provides a new therapeutic option to

Clinical Trials: Heart Disease and Stroke

There are more than 2,000 clinical trials listed in the National Institutes of Health database – www.clinicaltrials.gov – for heart disease and stroke.  Of those trials, more than 400 are either recruiting patients or have not yet started recruiting patients.  This information is potentially valuable to patients still seeking effective treatments for heart disease or stroke.  It provides a new therapeutic option to discuss with physicians.  For current information about the clinical trials that are recruiting or about to recruit patients, please c

Clinical Trials: Blood Cancers

There are 1,679 clinical trials listed in the National Institutes of Health database --www.clinicaltrials.gov -- for blood cancers.  Of those trials, 484 are either recruiting patients or have not yet started recruiting patients. This information is potentially valuable to patients still seeking effective treatments for leukemia, lymphoma, myeloma or other cancers of the blood. It provides a new therapeutic option to discuss with physicians.

Rx Minute: Higher Copays Slow Start of Treatment for Patients with Chronic Conditions

A 2009 study by RAND researchers, sponsored by the Agency for Healthcare Research and Quality (AHRQ) and published in the Archives of Internal Medicine, found that with higher copayments, patients who are newly diagnosed with chronic diseases are slower to begin drug treatments. The authors state that out of pocket costs “may prevent patients from initiating medically necessary care.”

Rx Minute: Early HIV Treatment May Improve Survival

A new study published in the New England Journal of Medicine suggests that the initiation of antiretroviral therapy earlier in the course of HIV infection may improve survival.

Rx Minute: Sustaining Biologics R&D; Potential Impact of FOB Legislation

Sustaining Biologics R&D; Potential Impact of FOB Legislation

Pages

Subscribe to RSS - Publications